SAN DIEGO — Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink (NASDAQ Stockholm: BICO) filed against it in Delaware court in 2021. At issue in this lawsuit is whether Cellink is infringing Organovo patents. Organovo, as one of the earliest and most prominent 3D bioprinting companies, has built […]
New York and Cambridge, MA — Gencove, a pioneer of low-pass whole genome sequencing (LPWGS) analysis, and BGI Americas Corporation, US subsidiary of BGI Genomics Co. Ltd. (300676.SZ), one of the world’s leading multi-omics companies, today announced the extension of the subscription and joint marketing agreements. The partnership combines BGI’s sequencing services from proprietary DNBSEQ™ […]
Pfizer and Codex DNA agree to strategic, multiyear, early access research collaboration, leveraging Codex DNA’s novel enzymatic DNA synthesis (EDS) technology Pfizer’s successful development and commercialization of licensed products could result in milestone payments in excess of $100 million SAN DIEGO — Codex DNA, Inc. (NASDAQ: DNAY), a leader in the development of automated solutions […]
NASHVILLE, Tenn. — Today, Nashville Biosciences, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), announced an agreement with Illumina, a leading genomic technology company, to realize the full potential of VUMC’s DNA databank, BioVU®. The agreement is a continuation of Vanderbilt’s long-term effort around BioVU and will accelerate genomic sequencing, resulting in new discoveries to advance […]
Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing and to bring improved insights to patients with breast cancer globally SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for […]
Collaboration will transform new insights into drug discovery and therapy development through large-scale genomics SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using […]
BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has joined the company as the Chief Business Officer. In this newly created role, Adam will have broad responsibility across SomaLogic’s rapidly growing business to drive the company’s strategic and business development goals. He will also serve as […]
SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer. The partnership spans current and future CDx programs, with plans […]
Inscripta®, the Digital Genome Engineering Company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, has adopted the Onyx® Genome Engineering Platform in its foundries. BOULDER, CO. — Inscripta®, the Digital Genome Engineering Company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, has adopted the Onyx® Genome Engineering Platform in its foundries. Ginkgo’s investment is part […]
GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that management will discuss the following business updates at the 40th Annual J.P. Morgan Healthcare Conference. Commercial update Quantum-Si has established list prices for its end-to-end protein sequencing platform as follows: $70,000 […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
